Global Non-benzodiazepine Hypnotics Market Growth (Status and Outlook) 2026-2032
The global Non-benzodiazepine Hypnotics market size is predicted to grow from US$ 1156 million in 2025 to US$ 1421 million in 2032; it is expected to grow at a CAGR of 3.0% from 2026 to 2032.
Non-benzodiazepine hypnotics are prescription Z-drugs, primarily including zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly produce sedative and hypnotic effects by modulating the GABA_A receptor complex and are used to treat difficulty initiating sleep, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, sublingual tablets, orally disintegrating tablets, capsules, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with pharmaceutical excipients, coating materials, capsule shells, blister packaging, and other pharmaceutical packaging materials. Downstream customers mainly include hospitals, psychiatric and sleep clinics, retail pharmacies, pharmaceutical wholesalers, and regulated online prescription platforms. Generic competition is relatively intense, while differentiated dosage forms and branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, non-benzodiazepine hypnotics have developed into a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Regional structures differ: the United States relies mainly on zolpidem and eszopiclone, zopiclone is more widely used in Europe, Canada, and parts of Asia, and China uses zolpidem, zopiclone, and eszopiclone under controlled-drug manufacturing, distribution, and prescribing requirements.
Looking ahead, market development will focus increasingly on dosage-form optimization, lower-dose treatment, individualized dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual products, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will strengthen risk management relating to next-day impairment, complex sleep behaviors, falls in older patients, and dependence, while improving prescription review, packaging controls, and patient education.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, psychiatric comorbidities, and improving recognition of sleep disorders. Z-drugs have long-established clinical use, rapid onset, broad physician familiarity, and lower treatment costs than many newer insomnia medicines. These characteristics support continued use in primary care, hospital, and retail prescription markets. Wider generic availability also improves affordability and market access in lower- and middle-income countries.
The main constraints include risks of tolerance, dependence, misuse, withdrawal, next-day cognitive and motor impairment, and complex sleep behaviors. Many countries impose controlled-drug rules and limits on prescription duration. Cognitive behavioral therapy for insomnia, digital sleep interventions, orexin receptor antagonists, and other new-mechanism treatments will divert some chronic-insomnia patients. In addition, centralized procurement, reimbursement controls, and generic competition will continue to reduce average selling prices, limiting revenue growth despite increasing treatment volume.
LPI (LP Information)' newest research report, the “Non-benzodiazepine Hypnotics Industry Forecast” looks at past sales and reviews total world Non-benzodiazepine Hypnotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-benzodiazepine Hypnotics sales for 2026 through 2032. With Non-benzodiazepine Hypnotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-benzodiazepine Hypnotics industry.
This Insight Report provides a comprehensive analysis of the global Non-benzodiazepine Hypnotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-benzodiazepine Hypnotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-benzodiazepine Hypnotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-benzodiazepine Hypnotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-benzodiazepine Hypnotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-benzodiazepine Hypnotics market by product type, application, key players and key regions and countries.
Non-benzodiazepine hypnotics are prescription Z-drugs, primarily including zolpidem, zopiclone, eszopiclone, and zaleplon. Although chemically distinct from conventional benzodiazepines, they mainly produce sedative and hypnotic effects by modulating the GABA_A receptor complex and are used to treat difficulty initiating sleep, frequent nocturnal awakening, early awakening, and sleep-maintenance insomnia. Major dosage forms include immediate-release tablets, extended-release tablets, sublingual tablets, orally disintegrating tablets, capsules, and oral sprays. Upstream inputs mainly include zolpidem tartrate, zopiclone, eszopiclone, and zaleplon active pharmaceutical ingredients, together with pharmaceutical excipients, coating materials, capsule shells, blister packaging, and other pharmaceutical packaging materials. Downstream customers mainly include hospitals, psychiatric and sleep clinics, retail pharmacies, pharmaceutical wholesalers, and regulated online prescription platforms. Generic competition is relatively intense, while differentiated dosage forms and branded products retain higher added value, with an overall gross margin generally ranging from approximately 45% to 68%.
From the current market perspective, non-benzodiazepine hypnotics have developed into a mature market dominated by zolpidem, with zopiclone and eszopiclone representing important secondary segments and zaleplon accounting for a relatively small share. All major active ingredients are exposed to generic competition, and standard tablets are supplied by numerous manufacturers. Regional structures differ: the United States relies mainly on zolpidem and eszopiclone, zopiclone is more widely used in Europe, Canada, and parts of Asia, and China uses zolpidem, zopiclone, and eszopiclone under controlled-drug manufacturing, distribution, and prescribing requirements.
Looking ahead, market development will focus increasingly on dosage-form optimization, lower-dose treatment, individualized dosing, and medication safety. Standard tablets will continue to account for most volume, while extended-release tablets, sublingual products, oral sprays, and low-dose products for middle-of-the-night awakening offer greater differentiation. Manufacturers will strengthen risk management relating to next-day impairment, complex sleep behaviors, falls in older patients, and dependence, while improving prescription review, packaging controls, and patient education.
Key market drivers include faster-paced lifestyles, psychological stress, population aging, psychiatric comorbidities, and improving recognition of sleep disorders. Z-drugs have long-established clinical use, rapid onset, broad physician familiarity, and lower treatment costs than many newer insomnia medicines. These characteristics support continued use in primary care, hospital, and retail prescription markets. Wider generic availability also improves affordability and market access in lower- and middle-income countries.
The main constraints include risks of tolerance, dependence, misuse, withdrawal, next-day cognitive and motor impairment, and complex sleep behaviors. Many countries impose controlled-drug rules and limits on prescription duration. Cognitive behavioral therapy for insomnia, digital sleep interventions, orexin receptor antagonists, and other new-mechanism treatments will divert some chronic-insomnia patients. In addition, centralized procurement, reimbursement controls, and generic competition will continue to reduce average selling prices, limiting revenue growth despite increasing treatment volume.
LPI (LP Information)' newest research report, the “Non-benzodiazepine Hypnotics Industry Forecast” looks at past sales and reviews total world Non-benzodiazepine Hypnotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-benzodiazepine Hypnotics sales for 2026 through 2032. With Non-benzodiazepine Hypnotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-benzodiazepine Hypnotics industry.
This Insight Report provides a comprehensive analysis of the global Non-benzodiazepine Hypnotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-benzodiazepine Hypnotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-benzodiazepine Hypnotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-benzodiazepine Hypnotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-benzodiazepine Hypnotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-benzodiazepine Hypnotics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Zolpidem
- Zopiclone
- Eszopiclone
- Zaleplon
Segmentation by Dosage Form:
- Tablets
- Capsules
- Other
Segmentation by Product Status:
- Originator Drugs
- Generic Drugs
Segmentation by Application:
- Hospitals
- Clinics
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cosette Pharmaceuticals
- Sanofi
- Sumitomo Pharma
- Teva Pharmaceutical Industries
- Viatris
- Sandoz
- Aurobindo Pharma
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- Torrent Pharmaceuticals
- Lupin
- Jiangsu Nhwa Pharmaceutical
- Shanghai Pharmaceuticals
- Qilu Pharmaceutical
- Chengdu Kanghong Pharmaceutical Group
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-benzodiazepine Hypnotics Market Size (2021-2032)
2.1.2 Non-benzodiazepine Hypnotics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-benzodiazepine Hypnotics by Country/Region (2021, 2025 & 2032)
2.2 Non-benzodiazepine Hypnotics Segment by Type
2.2.1 Zolpidem
2.2.2 Zopiclone
2.2.3 Eszopiclone
2.2.4 Zaleplon
2.2.5 Non-benzodiazepine Hypnotics Market Size by Type
2.2.5.1 Non-benzodiazepine Hypnotics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
2.3 Non-benzodiazepine Hypnotics Segment by Dosage Form
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Other
2.3.4 Non-benzodiazepine Hypnotics Market Size by Dosage Form
2.3.4.1 Non-benzodiazepine Hypnotics Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form (2021-2026)
2.4 Non-benzodiazepine Hypnotics Segment by Product Status
2.4.1 Originator Drugs
2.4.2 Generic Drugs
2.4.3 Non-benzodiazepine Hypnotics Market Size by Product Status
2.4.3.1 Non-benzodiazepine Hypnotics Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.4.3.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status (2021-2026)
2.5 Non-benzodiazepine Hypnotics Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 Non-benzodiazepine Hypnotics Market Size by Application
2.5.4.1 Non-benzodiazepine Hypnotics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
3 NON-BENZODIAZEPINE HYPNOTICS MARKET SIZE BY PLAYER
3.1 Non-benzodiazepine Hypnotics Market Size Market Share by Player
3.1.1 Global Non-benzodiazepine Hypnotics Revenue by Player (2021-2026)
3.1.2 Global Non-benzodiazepine Hypnotics Revenue Market Share by Player (2021-2026)
3.2 Global Non-benzodiazepine Hypnotics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-BENZODIAZEPINE HYPNOTICS BY REGION
4.1 Non-benzodiazepine Hypnotics Market Size by Region (2021-2026)
4.2 Global Non-benzodiazepine Hypnotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.4 APAC Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.5 Europe Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
5.2 Americas Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
5.3 Americas Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-benzodiazepine Hypnotics Market Size by Region (2021-2026)
6.2 APAC Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
6.3 APAC Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
7.2 Europe Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
7.3 Europe Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-benzodiazepine Hypnotics by Region (2021-2026)
8.2 Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-BENZODIAZEPINE HYPNOTICS MARKET FORECAST
10.1 Global Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.1.1 Global Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.1.2 Americas Non-benzodiazepine Hypnotics Forecast
10.1.3 APAC Non-benzodiazepine Hypnotics Forecast
10.1.4 Europe Non-benzodiazepine Hypnotics Forecast
10.1.5 Middle East & Africa Non-benzodiazepine Hypnotics Forecast
10.2 Americas Non-benzodiazepine Hypnotics Forecast by Country (2027-2032)
10.2.1 United States Market Non-benzodiazepine Hypnotics Forecast
10.2.2 Canada Market Non-benzodiazepine Hypnotics Forecast
10.2.3 Mexico Market Non-benzodiazepine Hypnotics Forecast
10.2.4 Brazil Market Non-benzodiazepine Hypnotics Forecast
10.3 APAC Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.3.1 China Non-benzodiazepine Hypnotics Market Forecast
10.3.2 Japan Market Non-benzodiazepine Hypnotics Forecast
10.3.3 Korea Market Non-benzodiazepine Hypnotics Forecast
10.3.4 Southeast Asia Market Non-benzodiazepine Hypnotics Forecast
10.3.5 India Market Non-benzodiazepine Hypnotics Forecast
10.3.6 Australia Market Non-benzodiazepine Hypnotics Forecast
10.4 Europe Non-benzodiazepine Hypnotics Forecast by Country (2027-2032)
10.4.1 Germany Market Non-benzodiazepine Hypnotics Forecast
10.4.2 France Market Non-benzodiazepine Hypnotics Forecast
10.4.3 UK Market Non-benzodiazepine Hypnotics Forecast
10.4.4 Italy Market Non-benzodiazepine Hypnotics Forecast
10.4.5 Russia Market Non-benzodiazepine Hypnotics Forecast
10.5 Middle East & Africa Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-benzodiazepine Hypnotics Forecast
10.5.2 South Africa Market Non-benzodiazepine Hypnotics Forecast
10.5.3 Israel Market Non-benzodiazepine Hypnotics Forecast
10.5.4 Turkey Market Non-benzodiazepine Hypnotics Forecast
10.6 Global Non-benzodiazepine Hypnotics Forecast by Type (2027-2032)
10.7 Global Non-benzodiazepine Hypnotics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-benzodiazepine Hypnotics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cosette Pharmaceuticals
11.1.1 Cosette Pharmaceuticals Company Information
11.1.2 Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.1.3 Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cosette Pharmaceuticals Main Business Overview
11.1.5 Cosette Pharmaceuticals Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Non-benzodiazepine Hypnotics Product Offered
11.2.3 Sanofi Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Sumitomo Pharma
11.3.1 Sumitomo Pharma Company Information
11.3.2 Sumitomo Pharma Non-benzodiazepine Hypnotics Product Offered
11.3.3 Sumitomo Pharma Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sumitomo Pharma Main Business Overview
11.3.5 Sumitomo Pharma Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
11.4.3 Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Viatris
11.5.1 Viatris Company Information
11.5.2 Viatris Non-benzodiazepine Hypnotics Product Offered
11.5.3 Viatris Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Viatris Main Business Overview
11.5.5 Viatris Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Non-benzodiazepine Hypnotics Product Offered
11.6.3 Sandoz Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Non-benzodiazepine Hypnotics Product Offered
11.7.3 Aurobindo Pharma Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Information
11.8.2 Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
11.8.3 Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sun Pharmaceutical Industries Main Business Overview
11.8.5 Sun Pharmaceutical Industries Latest Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Information
11.9.2 Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Product Offered
11.9.3 Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Dr. Reddy's Laboratories Main Business Overview
11.9.5 Dr. Reddy's Laboratories Latest Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Information
11.10.2 Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.10.3 Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Torrent Pharmaceuticals Main Business Overview
11.10.5 Torrent Pharmaceuticals Latest Developments
11.11 Lupin
11.11.1 Lupin Company Information
11.11.2 Lupin Non-benzodiazepine Hypnotics Product Offered
11.11.3 Lupin Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lupin Main Business Overview
11.11.5 Lupin Latest Developments
11.12 Jiangsu Nhwa Pharmaceutical
11.12.1 Jiangsu Nhwa Pharmaceutical Company Information
11.12.2 Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
11.12.3 Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.12.5 Jiangsu Nhwa Pharmaceutical Latest Developments
11.13 Shanghai Pharmaceuticals
11.13.1 Shanghai Pharmaceuticals Company Information
11.13.2 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.13.3 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Shanghai Pharmaceuticals Main Business Overview
11.13.5 Shanghai Pharmaceuticals Latest Developments
11.14 Qilu Pharmaceutical
11.14.1 Qilu Pharmaceutical Company Information
11.14.2 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
11.14.3 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Qilu Pharmaceutical Main Business Overview
11.14.5 Qilu Pharmaceutical Latest Developments
11.15 Chengdu Kanghong Pharmaceutical Group
11.15.1 Chengdu Kanghong Pharmaceutical Group Company Information
11.15.2 Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Product Offered
11.15.3 Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
11.15.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-benzodiazepine Hypnotics Market Size (2021-2032)
2.1.2 Non-benzodiazepine Hypnotics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-benzodiazepine Hypnotics by Country/Region (2021, 2025 & 2032)
2.2 Non-benzodiazepine Hypnotics Segment by Type
2.2.1 Zolpidem
2.2.2 Zopiclone
2.2.3 Eszopiclone
2.2.4 Zaleplon
2.2.5 Non-benzodiazepine Hypnotics Market Size by Type
2.2.5.1 Non-benzodiazepine Hypnotics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
2.3 Non-benzodiazepine Hypnotics Segment by Dosage Form
2.3.1 Tablets
2.3.2 Capsules
2.3.3 Other
2.3.4 Non-benzodiazepine Hypnotics Market Size by Dosage Form
2.3.4.1 Non-benzodiazepine Hypnotics Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form (2021-2026)
2.4 Non-benzodiazepine Hypnotics Segment by Product Status
2.4.1 Originator Drugs
2.4.2 Generic Drugs
2.4.3 Non-benzodiazepine Hypnotics Market Size by Product Status
2.4.3.1 Non-benzodiazepine Hypnotics Market Size CAGR by Product Status (2021 VS 2025 VS 2032)
2.4.3.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status (2021-2026)
2.5 Non-benzodiazepine Hypnotics Segment by Application
2.5.1 Hospitals
2.5.2 Clinics
2.5.3 Other
2.5.4 Non-benzodiazepine Hypnotics Market Size by Application
2.5.4.1 Non-benzodiazepine Hypnotics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
3 NON-BENZODIAZEPINE HYPNOTICS MARKET SIZE BY PLAYER
3.1 Non-benzodiazepine Hypnotics Market Size Market Share by Player
3.1.1 Global Non-benzodiazepine Hypnotics Revenue by Player (2021-2026)
3.1.2 Global Non-benzodiazepine Hypnotics Revenue Market Share by Player (2021-2026)
3.2 Global Non-benzodiazepine Hypnotics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-BENZODIAZEPINE HYPNOTICS BY REGION
4.1 Non-benzodiazepine Hypnotics Market Size by Region (2021-2026)
4.2 Global Non-benzodiazepine Hypnotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.4 APAC Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.5 Europe Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-benzodiazepine Hypnotics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
5.2 Americas Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
5.3 Americas Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-benzodiazepine Hypnotics Market Size by Region (2021-2026)
6.2 APAC Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
6.3 APAC Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026)
7.2 Europe Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
7.3 Europe Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-benzodiazepine Hypnotics by Region (2021-2026)
8.2 Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-BENZODIAZEPINE HYPNOTICS MARKET FORECAST
10.1 Global Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.1.1 Global Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.1.2 Americas Non-benzodiazepine Hypnotics Forecast
10.1.3 APAC Non-benzodiazepine Hypnotics Forecast
10.1.4 Europe Non-benzodiazepine Hypnotics Forecast
10.1.5 Middle East & Africa Non-benzodiazepine Hypnotics Forecast
10.2 Americas Non-benzodiazepine Hypnotics Forecast by Country (2027-2032)
10.2.1 United States Market Non-benzodiazepine Hypnotics Forecast
10.2.2 Canada Market Non-benzodiazepine Hypnotics Forecast
10.2.3 Mexico Market Non-benzodiazepine Hypnotics Forecast
10.2.4 Brazil Market Non-benzodiazepine Hypnotics Forecast
10.3 APAC Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.3.1 China Non-benzodiazepine Hypnotics Market Forecast
10.3.2 Japan Market Non-benzodiazepine Hypnotics Forecast
10.3.3 Korea Market Non-benzodiazepine Hypnotics Forecast
10.3.4 Southeast Asia Market Non-benzodiazepine Hypnotics Forecast
10.3.5 India Market Non-benzodiazepine Hypnotics Forecast
10.3.6 Australia Market Non-benzodiazepine Hypnotics Forecast
10.4 Europe Non-benzodiazepine Hypnotics Forecast by Country (2027-2032)
10.4.1 Germany Market Non-benzodiazepine Hypnotics Forecast
10.4.2 France Market Non-benzodiazepine Hypnotics Forecast
10.4.3 UK Market Non-benzodiazepine Hypnotics Forecast
10.4.4 Italy Market Non-benzodiazepine Hypnotics Forecast
10.4.5 Russia Market Non-benzodiazepine Hypnotics Forecast
10.5 Middle East & Africa Non-benzodiazepine Hypnotics Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-benzodiazepine Hypnotics Forecast
10.5.2 South Africa Market Non-benzodiazepine Hypnotics Forecast
10.5.3 Israel Market Non-benzodiazepine Hypnotics Forecast
10.5.4 Turkey Market Non-benzodiazepine Hypnotics Forecast
10.6 Global Non-benzodiazepine Hypnotics Forecast by Type (2027-2032)
10.7 Global Non-benzodiazepine Hypnotics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-benzodiazepine Hypnotics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Cosette Pharmaceuticals
11.1.1 Cosette Pharmaceuticals Company Information
11.1.2 Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.1.3 Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Cosette Pharmaceuticals Main Business Overview
11.1.5 Cosette Pharmaceuticals Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Non-benzodiazepine Hypnotics Product Offered
11.2.3 Sanofi Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Sumitomo Pharma
11.3.1 Sumitomo Pharma Company Information
11.3.2 Sumitomo Pharma Non-benzodiazepine Hypnotics Product Offered
11.3.3 Sumitomo Pharma Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Sumitomo Pharma Main Business Overview
11.3.5 Sumitomo Pharma Latest Developments
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Information
11.4.2 Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
11.4.3 Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Teva Pharmaceutical Industries Main Business Overview
11.4.5 Teva Pharmaceutical Industries Latest Developments
11.5 Viatris
11.5.1 Viatris Company Information
11.5.2 Viatris Non-benzodiazepine Hypnotics Product Offered
11.5.3 Viatris Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Viatris Main Business Overview
11.5.5 Viatris Latest Developments
11.6 Sandoz
11.6.1 Sandoz Company Information
11.6.2 Sandoz Non-benzodiazepine Hypnotics Product Offered
11.6.3 Sandoz Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Sandoz Main Business Overview
11.6.5 Sandoz Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Non-benzodiazepine Hypnotics Product Offered
11.7.3 Aurobindo Pharma Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Information
11.8.2 Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
11.8.3 Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Sun Pharmaceutical Industries Main Business Overview
11.8.5 Sun Pharmaceutical Industries Latest Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Information
11.9.2 Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Product Offered
11.9.3 Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Dr. Reddy's Laboratories Main Business Overview
11.9.5 Dr. Reddy's Laboratories Latest Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Information
11.10.2 Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.10.3 Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Torrent Pharmaceuticals Main Business Overview
11.10.5 Torrent Pharmaceuticals Latest Developments
11.11 Lupin
11.11.1 Lupin Company Information
11.11.2 Lupin Non-benzodiazepine Hypnotics Product Offered
11.11.3 Lupin Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Lupin Main Business Overview
11.11.5 Lupin Latest Developments
11.12 Jiangsu Nhwa Pharmaceutical
11.12.1 Jiangsu Nhwa Pharmaceutical Company Information
11.12.2 Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
11.12.3 Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.12.5 Jiangsu Nhwa Pharmaceutical Latest Developments
11.13 Shanghai Pharmaceuticals
11.13.1 Shanghai Pharmaceuticals Company Information
11.13.2 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
11.13.3 Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Shanghai Pharmaceuticals Main Business Overview
11.13.5 Shanghai Pharmaceuticals Latest Developments
11.14 Qilu Pharmaceutical
11.14.1 Qilu Pharmaceutical Company Information
11.14.2 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
11.14.3 Qilu Pharmaceutical Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Qilu Pharmaceutical Main Business Overview
11.14.5 Qilu Pharmaceutical Latest Developments
11.15 Chengdu Kanghong Pharmaceutical Group
11.15.1 Chengdu Kanghong Pharmaceutical Group Company Information
11.15.2 Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Product Offered
11.15.3 Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
11.15.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-benzodiazepine Hypnotics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-benzodiazepine Hypnotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Zolpidem
Table 4. Major Players of Zopiclone
Table 5. Major Players of Eszopiclone
Table 6. Major Players of Zaleplon
Table 7. Non-benzodiazepine Hypnotics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Tablets
Table 11. Major Players of Capsules
Table 12. Major Players of Other
Table 13. Non-benzodiazepine Hypnotics Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Non-benzodiazepine Hypnotics Market Size by Dosage Form (2021-2026) & ($ millions)
Table 15. Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form (2021-2026)
Table 16. Major Players of Originator Drugs
Table 17. Major Players of Generic Drugs
Table 18. Non-benzodiazepine Hypnotics Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Non-benzodiazepine Hypnotics Market Size by Product Status (2021-2026) & ($ millions)
Table 20. Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status (2021-2026)
Table 21. Non-benzodiazepine Hypnotics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Table 24. Global Non-benzodiazepine Hypnotics Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Non-benzodiazepine Hypnotics Revenue Market Share by Player (2021-2026)
Table 26. Non-benzodiazepine Hypnotics Key Players Head office and Products Offered
Table 27. Non-benzodiazepine Hypnotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Table 32. Global Non-benzodiazepine Hypnotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-benzodiazepine Hypnotics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Country (2021-2026)
Table 36. Americas Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Table 38. Americas Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Table 40. APAC Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Table 42. APAC Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Country (2021-2026)
Table 46. Europe Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Non-benzodiazepine Hypnotics
Table 52. Key Market Challenges & Risks of Non-benzodiazepine Hypnotics
Table 53. Key Industry Trends of Non-benzodiazepine Hypnotics
Table 54. Global Non-benzodiazepine Hypnotics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Non-benzodiazepine Hypnotics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Non-benzodiazepine Hypnotics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Cosette Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 59. Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 60. Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Cosette Pharmaceuticals Main Business
Table 62. Cosette Pharmaceuticals Latest Developments
Table 63. Sanofi Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 64. Sanofi Non-benzodiazepine Hypnotics Product Offered
Table 65. Sanofi Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. Sumitomo Pharma Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 69. Sumitomo Pharma Non-benzodiazepine Hypnotics Product Offered
Table 70. Sumitomo Pharma Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sumitomo Pharma Main Business
Table 72. Sumitomo Pharma Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
Table 75. Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Viatris Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 79. Viatris Non-benzodiazepine Hypnotics Product Offered
Table 80. Viatris Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Viatris Main Business
Table 82. Viatris Latest Developments
Table 83. Sandoz Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 84. Sandoz Non-benzodiazepine Hypnotics Product Offered
Table 85. Sandoz Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Aurobindo Pharma Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 89. Aurobindo Pharma Non-benzodiazepine Hypnotics Product Offered
Table 90. Aurobindo Pharma Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Aurobindo Pharma Main Business
Table 92. Aurobindo Pharma Latest Developments
Table 93. Sun Pharmaceutical Industries Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 94. Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
Table 95. Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Sun Pharmaceutical Industries Main Business
Table 97. Sun Pharmaceutical Industries Latest Developments
Table 98. Dr. Reddy's Laboratories Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 99. Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Product Offered
Table 100. Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Dr. Reddy's Laboratories Main Business
Table 102. Dr. Reddy's Laboratories Latest Developments
Table 103. Torrent Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 104. Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 105. Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Torrent Pharmaceuticals Main Business
Table 107. Torrent Pharmaceuticals Latest Developments
Table 108. Lupin Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 109. Lupin Non-benzodiazepine Hypnotics Product Offered
Table 110. Lupin Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Lupin Main Business
Table 112. Lupin Latest Developments
Table 113. Jiangsu Nhwa Pharmaceutical Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 114. Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
Table 115. Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Jiangsu Nhwa Pharmaceutical Main Business
Table 117. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 118. Shanghai Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 119. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 120. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Shanghai Pharmaceuticals Main Business
Table 122. Shanghai Pharmaceuticals Latest Developments
Table 123. Qilu Pharmaceutical Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 124. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
Table 125. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Chengdu Kanghong Pharmaceutical Group Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 129. Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Product Offered
Table 130. Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Chengdu Kanghong Pharmaceutical Group Main Business
Table 132. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 1. Non-benzodiazepine Hypnotics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-benzodiazepine Hypnotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Zolpidem
Table 4. Major Players of Zopiclone
Table 5. Major Players of Eszopiclone
Table 6. Major Players of Zaleplon
Table 7. Non-benzodiazepine Hypnotics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Tablets
Table 11. Major Players of Capsules
Table 12. Major Players of Other
Table 13. Non-benzodiazepine Hypnotics Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Non-benzodiazepine Hypnotics Market Size by Dosage Form (2021-2026) & ($ millions)
Table 15. Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form (2021-2026)
Table 16. Major Players of Originator Drugs
Table 17. Major Players of Generic Drugs
Table 18. Non-benzodiazepine Hypnotics Market Size CAGR by Product Status (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Non-benzodiazepine Hypnotics Market Size by Product Status (2021-2026) & ($ millions)
Table 20. Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status (2021-2026)
Table 21. Non-benzodiazepine Hypnotics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 23. Global Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Table 24. Global Non-benzodiazepine Hypnotics Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Non-benzodiazepine Hypnotics Revenue Market Share by Player (2021-2026)
Table 26. Non-benzodiazepine Hypnotics Key Players Head office and Products Offered
Table 27. Non-benzodiazepine Hypnotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Table 32. Global Non-benzodiazepine Hypnotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-benzodiazepine Hypnotics Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Country (2021-2026)
Table 36. Americas Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Table 38. Americas Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Table 40. APAC Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Table 42. APAC Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe Non-benzodiazepine Hypnotics Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Country (2021-2026)
Table 46. Europe Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa Non-benzodiazepine Hypnotics Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Non-benzodiazepine Hypnotics
Table 52. Key Market Challenges & Risks of Non-benzodiazepine Hypnotics
Table 53. Key Industry Trends of Non-benzodiazepine Hypnotics
Table 54. Global Non-benzodiazepine Hypnotics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Non-benzodiazepine Hypnotics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global Non-benzodiazepine Hypnotics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Cosette Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 59. Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 60. Cosette Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Cosette Pharmaceuticals Main Business
Table 62. Cosette Pharmaceuticals Latest Developments
Table 63. Sanofi Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 64. Sanofi Non-benzodiazepine Hypnotics Product Offered
Table 65. Sanofi Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Sanofi Main Business
Table 67. Sanofi Latest Developments
Table 68. Sumitomo Pharma Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 69. Sumitomo Pharma Non-benzodiazepine Hypnotics Product Offered
Table 70. Sumitomo Pharma Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Sumitomo Pharma Main Business
Table 72. Sumitomo Pharma Latest Developments
Table 73. Teva Pharmaceutical Industries Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 74. Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
Table 75. Teva Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Teva Pharmaceutical Industries Main Business
Table 77. Teva Pharmaceutical Industries Latest Developments
Table 78. Viatris Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 79. Viatris Non-benzodiazepine Hypnotics Product Offered
Table 80. Viatris Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Viatris Main Business
Table 82. Viatris Latest Developments
Table 83. Sandoz Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 84. Sandoz Non-benzodiazepine Hypnotics Product Offered
Table 85. Sandoz Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Aurobindo Pharma Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 89. Aurobindo Pharma Non-benzodiazepine Hypnotics Product Offered
Table 90. Aurobindo Pharma Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Aurobindo Pharma Main Business
Table 92. Aurobindo Pharma Latest Developments
Table 93. Sun Pharmaceutical Industries Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 94. Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Product Offered
Table 95. Sun Pharmaceutical Industries Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Sun Pharmaceutical Industries Main Business
Table 97. Sun Pharmaceutical Industries Latest Developments
Table 98. Dr. Reddy's Laboratories Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 99. Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Product Offered
Table 100. Dr. Reddy's Laboratories Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Dr. Reddy's Laboratories Main Business
Table 102. Dr. Reddy's Laboratories Latest Developments
Table 103. Torrent Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 104. Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 105. Torrent Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Torrent Pharmaceuticals Main Business
Table 107. Torrent Pharmaceuticals Latest Developments
Table 108. Lupin Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 109. Lupin Non-benzodiazepine Hypnotics Product Offered
Table 110. Lupin Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Lupin Main Business
Table 112. Lupin Latest Developments
Table 113. Jiangsu Nhwa Pharmaceutical Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 114. Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
Table 115. Jiangsu Nhwa Pharmaceutical Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Jiangsu Nhwa Pharmaceutical Main Business
Table 117. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 118. Shanghai Pharmaceuticals Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 119. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product Offered
Table 120. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Shanghai Pharmaceuticals Main Business
Table 122. Shanghai Pharmaceuticals Latest Developments
Table 123. Qilu Pharmaceutical Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 124. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product Offered
Table 125. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Chengdu Kanghong Pharmaceutical Group Details, Company Type, Non-benzodiazepine Hypnotics Area Served and Its Competitors
Table 129. Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Product Offered
Table 130. Chengdu Kanghong Pharmaceutical Group Non-benzodiazepine Hypnotics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Chengdu Kanghong Pharmaceutical Group Main Business
Table 132. Chengdu Kanghong Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Non-benzodiazepine Hypnotics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-benzodiazepine Hypnotics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-benzodiazepine Hypnotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-benzodiazepine Hypnotics Sales Market Share by Country/Region (2025)
Figure 8. Non-benzodiazepine Hypnotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-benzodiazepine Hypnotics Market Size Market Share by Type in 2025
Figure 10. Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form in 2025
Figure 11. Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status in 2025
Figure 12. Non-benzodiazepine Hypnotics in Hospitals
Figure 13. Global Non-benzodiazepine Hypnotics Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Non-benzodiazepine Hypnotics in Clinics
Figure 15. Global Non-benzodiazepine Hypnotics Market: Clinics (2021-2026) & ($ millions)
Figure 16. Non-benzodiazepine Hypnotics in Other
Figure 17. Global Non-benzodiazepine Hypnotics Market: Other (2021-2026) & ($ millions)
Figure 18. Global Non-benzodiazepine Hypnotics Market Size Market Share by Application in 2025
Figure 19. Global Non-benzodiazepine Hypnotics Revenue Market Share by Player in 2025
Figure 20. Global Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 22. APAC Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 23. Europe Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 25. Americas Non-benzodiazepine Hypnotics Value Market Share by Country in 2025
Figure 26. United States Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Region in 2025
Figure 31. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 33. China Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Country in 2025
Figure 40. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 56. APAC Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 57. Europe Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 59. United States Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 60. Canada Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 63. China Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 64. Japan Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 65. Korea Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 67. India Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 68. Australia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 69. Germany Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 70. France Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 71. UK Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 72. Italy Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 73. Russia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 76. Israel Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 78. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 1. Non-benzodiazepine Hypnotics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-benzodiazepine Hypnotics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-benzodiazepine Hypnotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-benzodiazepine Hypnotics Sales Market Share by Country/Region (2025)
Figure 8. Non-benzodiazepine Hypnotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-benzodiazepine Hypnotics Market Size Market Share by Type in 2025
Figure 10. Global Non-benzodiazepine Hypnotics Market Size Market Share by Dosage Form in 2025
Figure 11. Global Non-benzodiazepine Hypnotics Market Size Market Share by Product Status in 2025
Figure 12. Non-benzodiazepine Hypnotics in Hospitals
Figure 13. Global Non-benzodiazepine Hypnotics Market: Hospitals (2021-2026) & ($ millions)
Figure 14. Non-benzodiazepine Hypnotics in Clinics
Figure 15. Global Non-benzodiazepine Hypnotics Market: Clinics (2021-2026) & ($ millions)
Figure 16. Non-benzodiazepine Hypnotics in Other
Figure 17. Global Non-benzodiazepine Hypnotics Market: Other (2021-2026) & ($ millions)
Figure 18. Global Non-benzodiazepine Hypnotics Market Size Market Share by Application in 2025
Figure 19. Global Non-benzodiazepine Hypnotics Revenue Market Share by Player in 2025
Figure 20. Global Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Figure 21. Americas Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 22. APAC Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 23. Europe Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Non-benzodiazepine Hypnotics Market Size 2021-2026 ($ millions)
Figure 25. Americas Non-benzodiazepine Hypnotics Value Market Share by Country in 2025
Figure 26. United States Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Region in 2025
Figure 31. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 32. APAC Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 33. China Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 37. India Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Country in 2025
Figure 40. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 41. Europe Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 42. Germany Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 43. France Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Non-benzodiazepine Hypnotics Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Non-benzodiazepine Hypnotics Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 56. APAC Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 57. Europe Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 59. United States Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 60. Canada Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 61. Mexico Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 62. Brazil Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 63. China Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 64. Japan Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 65. Korea Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 67. India Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 68. Australia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 69. Germany Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 70. France Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 71. UK Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 72. Italy Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 73. Russia Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 74. Egypt Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 75. South Africa Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 76. Israel Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 77. Turkey Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
Figure 78. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Non-benzodiazepine Hypnotics Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Non-benzodiazepine Hypnotics Market Size 2027-2032 ($ millions)
